SI-BONE, Inc.
SIBN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.62 | 4.91 | -0.62 | 1.05 |
| FCF Yield | -0.10% | -0.24% | -1.18% | -0.18% |
| EV / EBITDA | -268.08 | -196.23 | -128.20 | -237.56 |
| Quality | ||||
| ROIC | -2.58% | -3.38% | -3.66% | -2.69% |
| Gross Margin | 79.84% | 79.80% | 79.71% | 79.13% |
| Cash Conversion Ratio | -0.51 | -0.03 | 0.75 | -0.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 13.62% | 14.20% | 14.82% | 16.25% |
| Free Cash Flow Growth | 67.81% | 72.42% | -541.82% | 60.20% |
| Safety | ||||
| Net Debt / EBITDA | -4.29 | -0.68 | 0.88 | -1.02 |
| Interest Coverage | -8.03 | -10.52 | -11.30 | -6.93 |
| Efficiency | ||||
| Inventory Turnover | 0.27 | 0.29 | 0.32 | 0.38 |
| Cash Conversion Cycle | 305.99 | 290.19 | 263.50 | 231.63 |